The global surgical stapling devices market is estimated to account for US$ 4,364.6 Mn in terms of value by the end of 2027.

Surgical Stapling Devices Market are staplers used in surgical procedures to seal or close wounds or incised areas of the body. These are specialist equipment that can be used to seal or close wounds on both the inside and outside.

Drivers of the Global Surgical Stapling Devices Market

Over the forecast period, the global Surgical Stapling Devices Market is expected to rise due to the rising prevalence of obesity. Obesity affects 71424.3 thousand persons in the United States, according to the Centers for Disease Control and Prevention's Behavioral Risk Factor Surveillance System.

Furthermore, the industry is predicted to rise as the geriatric population grows. According to the United States Census Bureau, the elderly population in the United States is predicted to reach 77 million by 2034.

Statistics:

In terms of value, North America dominated the global surgical stapling devices market in 2019, with a 28.6 percent share, followed by Europe and the Asia Pacific, respectively.

Restraints in the Global Surgical Stapling Devices Market

The use of surgical stapling devices can result in harm when the stapler is removed, which is predicted to limit the market growth.

Opportunities in the Global Surgical Stapling Devices Market

For companies in the global surgical stapling devices market, R&D in device functionality is likely to provide lucrative growth prospects.

Major players operating in the global surgical stapling devices market include Medtronic plc, Johnson & Johnson, 3M Company, Aesculap, Inc. (B. Braun), SeCQure Surgical Corporation, Purple Surgical Holdings Limited, Meril Life Sciences Pvt. Ltd., and Grena Ltd.